Ginzel, J. D. | bioRxiv Science

bioRxiv2025

CoSiDeX: A hyperspectral fluorescent protein resource for highly multiplexed imaging

Fluorescent proteins (FPs) have revolutionized spatiotemporal observations in biology. Yet, the design of multiplexed assays remains constrained by limited spectral characterization and palette validation. Although over 1,000 FPs have been catalogued, systematic resources for characterizing their use in multiplexed approaches are lacking. Here we present a resource and methodology for selecting and decoding FPs in multiplexed imaging experiments. A library of forty-four FPs was built for rapid assembly into mammalian expression vectors and transposase-mediated integration. Hyperspectral imaging was performed for each FP and spectral space was characterized mathematically. To support experimental design and data interpretation, we developed the Cosine Similarity Decoder of XFP (CoSiDeX) toolbox, to predict spectrally resolvable FP palettes and decode and re-color hyperspectral images. Using this approach, we demonstrate live-cell imaging of 12 uniquely labeled clones. Our work offers a scalable platform for selecting optimal FP palettes for multiplex experiments, with broad utility across diverse biological systems and hyperspectral imaging techniques.

molecular biology↗

bioRxiv2024

Nonlinear progression across the occult transition establishes cancer lethality

Cancer screening is based upon a linear model of neoplastic growth and malignant progression. Yet, historical observations suggest that malignant progression is uncoupled from growth which may explain the paradoxical increase in early-stage breast cancer detection without a dramatic reduction in metastatic burden. Here we lineage trace millions of genetically transformed field cells and thousands of screen detectable and symptomatic tumors using a cancer rainbow mouse model of HER2+ breast cancer. Transition rates from field cell to screen detectable tumor and then to symptomatic tumors were estimated from a dynamical model of tumor development. Field cells are orders of magnitude less likely to transition to a screen detectable tumor than the subsequent transition of a screen detectable tumor to a symptomatic tumor. Our model supports a critical occult transition in tumor development during which time a transformed cell becomes a bona fide neoplasm. Lineage tracing and test-by-transplantation reveals that nonlinear progression during or prior to the occult transition gives rise to nascent lethal cancers at screen detection. Simulations illustrate how occult transition rates are a critical determinant of tumor growth and malignancy in the lifetime of a host. Our data provides direct experimental evidence that cancers can deviate from the predictable linear progression model foundational to current screening paradigms

cancer biology↗